文献速递垂体与肾上腺疾病

正常血压与高血压嗜铬细胞瘤患者的术后结局:一项国际研究

Postoperative Outcomes in Normotensive and Hypertensive Pheochromocytomas: An International Study.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

这项国际回顾性研究纳入2012至2022年间46个中心接受肾上腺切除术的2016例嗜铬细胞瘤患者,其中1034例(51.2%)术前有高血压、982例(49.8%)血压正常。未校正分析显示高血压组手术时间更长、血管加压药使用率更高、围术期输血更多、并发症率更高,但经1:1倾向性评分匹配后,两组再入院、并发症及严重并发症相似。

要点

  • 高血压嗜铬细胞瘤患者年龄更大、合并症负担更重、美国麻醉医师学会评分III至IV级比例更高。
  • 未校正分析中高血压组手术时间更长、围术期输血更多、并发症率更高。
  • 经1:1倾向性评分匹配后,两组再入院、并发症及严重并发症相似。

核心结论

  • 高血压嗜铬细胞瘤患者术后并发症风险高于血压正常患者,源于高血压与更重合并症负担及年龄更大相关。
  • 高血压并非嗜铬细胞瘤术后并发症的独立危险因素。

研究设计与样本

  • 国际回顾性研究,纳入2012年至2022年间46个中心接受肾上腺切除术的嗜铬细胞瘤患者2016例。
  • 高血压嗜铬细胞瘤定义为诊断前或诊断时存在高血压病史,否则为血压正常嗜铬细胞瘤。
  • 采用倾向性评分匹配(PSM)分析比较高血压与血压正常患者的术后结局差异。

主要发现

  • 2016例中高血压组1034例(51.2%),血压正常组982例(49.8%)。
  • 高血压组较血压正常组年龄大4.5岁(P < .001),2型糖尿病患病率更高(P < .001)。
  • 高血压组Charlson合并症指数中位数2.0 vs 血压正常组1.0(P < .001)。
  • 高血压组美国麻醉医师学会评分III至IV级比例41% vs 血压正常组19.9%(P < .001)。
  • 未校正分析:高血压组手术时间115.0 vs 103.5分钟(P = .026),关皮时使用血管加压药19.7% vs 15.4%(P = .013),围术期输血7.7% vs 5.0%(P = .016),并发症率21.6% vs 17.7%(P = .029)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Postoperative outcomes of patients with normotensive pheochromocytomas are poorly documented. OBJECTIVE: We aimed to evaluate the impact of preoperative hypertension on postoperative outcomes following adrenalectomy for pheochromocytoma. METHODS: An international retrospective study of patients undergoing adrenalectomy for pheochromocytoma in 46 centers between 2012 and 2022 was performed. Hypertensive and normotensive pheochromocytoma were defined respectively by the presence or absence of hypertension history before or at the time of pheochromocytoma diagnosis. To evaluate differences in postoperative outcomes between hypertensive and normotensive patients, propensity score matched (PSM) analysis was performed. RESULTS: Among 2016 patients with pheochromocytoma, 1034 (51.2%) had preoperative hypertension and 982 (49.8%) were normotensive. Hypertensive patients were 4.5 years older (P < .001), had a higher prevalence of type 2 diabetes (P < .001), had a higher median Charlson Comorbidity Index (2.0 vs 1.0; P < .001), and had an American Society of Anesthesiologists score of III to IV more frequently (41% vs 19.9%; P < .001) than normotensive patients. Nonadjusted analysis demonstrated that hypertensive patients had longer operative time (115.0 vs 103.5 minutes; P = .026), higher rate of vasopressors at skin closure (19.7% vs 15.4%; P = .013), more perioperative blood transfusions (7.7% vs 5.0%; P = .016), and an increased complication rate (21.6% vs 17.7%; P = .029). However, after 1:1 PSM, we found that readmission, complications, and serious complications were similar between cohorts. CONCLUSION: Patients with hypertensive pheochromocytomas have a higher risk of postoperative complications than normotensive patients due to the association of hypertension with a higher burden of comorbidities and older age. However, hypertension is not an independent risk factor of postoperative complications after pheochromocytoma surgery.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Araujo-Castro M, Herrera A, Wang Y, et al. Postoperative Outcomes in Normotensive and Hypertensive Pheochromocytomas: An International Study. J Clin Endocrinol Metab. 2025. PMID: 40048695. doi:10.1210/clinem/dgaf154

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。